Learn More About Medicines in Development for HIV/AIDS

America’s biopharmaceutical research companies are currently developing 73 innovative medicines and vaccines to help the nearly 1.2 million Americans living with HIV infection today, according to a new report from PhRMA. The medicines in development – all in either clinical trials or under review by the FDA – include 40 antivirals, 25 vaccines, four cell or gene therapies, and four immunomodulators. Examples of potential innovations included in the report include:

Code on Business Ethics

This Week #PhRMA13 Convenes a New Conversation on Research, Progress and Hope

04.08.13 | By

In just a few days, health care industry leaders, biomedical professionals and patients from across the country will convene at #PhRMA13 in San Diego to discuss the future of medicine and share ideas as to how we can all make PhRMA's mission of research, progress and hope an ongoing reality. The panels throughout the meeting will focus on this mission.

Questions and Answers for Peer Speakers Program for Health Care Professionals

Why do biopharmaceutical companies sponsor peer speaker programs for health care professionals?

Doctors and other healthcare professionals with real-world clinical experience in specific therapeutic areas are uniquely qualified to educate and inform their peers about the medicines they prescribe. While physicians consult many sources for information, it can be a challenge for them to juggle the demands of clinical practice with the need to stay up-to-date with the latest science and FDA-approved treatment options.


Read speeches, public addresses and congressional testimony by PhRMA CEO and President John Castellani and other pharmaceutical industry leaders. Click on any of the links below to read one of the speeches.

John J. Castellani 2014 Annual Meeting Remarks

Week In Review: When Minor Discoveries Make All The Difference

04.06.13 | By

Have you ever considered what it took to develop medicines, like aspirin, that we use regularly? It was far from an overnight discovery. The medicines we sometimes take for granted are the result of decades of intense research and development.

Press Room

PhRMApedia's Press Room provides the most recent press releases. Search PhRMApedia for additional press releases.

Incremental Innovation: Personalized Medicine Coalition Concludes our Series

04.05.13 | By

What a great week on the Catalyst! We heard several different perspectives on incremental innovation and the value that medicines provide to millions of patients suffering from disease.

Incremental Innovation Series: IFPMA and Biopharmaceutical Progress

04.05.13 | By

A recent report from the IFPMA (the International Federation of Pharmaceutical Manufacturers and Associations) adds to the growing body of work on the cumulative, step-wise nature of biopharmaceutical progress, with a particular focus on incremental innovation.

The National Hurricane Conference - Dialogue and Lessons Learned

04.05.13 | By

Last week at the National Hurricane Conference, Rx Response announced a new, easier-to-remember name and website for its much-praised pharmacy status reporting tool - Rx Open .


Subscribe to RSS - Opinion